In Reply Narod et al raise several concerns about our recent suggestion that women of Ashkenazi Jewish (AJ) ancestry consider comprehensive sequencing for inherited predisposition to breast and ovarian cancer. Our data1 led us to suggest that, given recent advances in sequencing technology and reductions in price, AJ women consider the same complete sequencing for all known breast cancer genes as women of other ancestries.
King M, Walsh T. Testing Ashkenazi Jewish Women for Mutations Predisposing to Breast Cancer in Genes Other Than BRCA1 and BRCA2—Reply. JAMA Oncol. 2018;4(7):1012–1013. doi:10.1001/jamaoncol.2018.0616
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: